(Press-News.org) A recent UCLA clinical trial has shown encouraging results in helping daily smokers who are also heavy drinkers quit smoking and cut down their alcohol intake.
The study of 165 people tested two prescription drugs -- varenicline, for smoking addiction, and naltrexone, which is used to treat alcoholism. Studies have shown that varenicline, marketed under the brand name Chantix, may also be effective in reducing alcohol consumption.
Participants, who ranged in age from 21 to 65, smoked at least five cigarettes a day, with male participants generally consuming more than 14 drinks a week and women more than seven per week.
Over the 12-week study period, each participant received 2 milligrams of varenicline twice a day. Roughly half the group -- 83 participants -- also received a 50-milligram dose of naltrexone daily, while the other 82 received placebo pills. They were all told to quit smoking and drink less.
When researchers followed up 26 weeks after the study's conclusion, they found that nearly 36% -- 59 participants -- had quit smoking.
"The overall smoking quit rate in the trial is impressive," said lead author Lara Ray, a professor of psychology and of psychiatry and biobehavioral sciences who holds UCLA's Shirley M. Hatos Chair in Clinical Neuropharmacology. She noted that previous studies have suggested varenicline has a success rate at six months of about 25% to 30%.
"We exceeded the overall expectation for this medication," she said. "This is especially important in a diverse group of people." Ray said that while some previous studies have shown lower-than-average smoking cessation rates among Black participants, that was not the case in the current trial, in which more than half of participants were Black.
Surprisingly, the researchers said, those who had received varenicline plus a placebo had a significantly higher smoking quit rate (45%, or 37 of 82 participants) than those who were given varenicline and naltrexone (27%, or 22 of 83 participants).
"The quit rate for varenicline alone in this sample is highly encouraging, as this is the first large-scale trial of varenicline efficacy focused solely on heavy-drinking smokers," Ray said.
While participants who received varenicline plus naltrexone had a lower smoking quit rate, they had slightly better success than the placebo group at curbing their drinking. At the start of the study, participants averaged nearly seven drinks per drinking day; those on the varenicline-naltrexone combination reduced their consumption to three drinks per drinking day over the 12-week study period, while those receiving the varenicline-placebo combination cut down to four drinks -- both impressive decreases, Ray said.
"I am excited about both the smoking cessation rates and the drinking reductions," said Ray, who is also a member of UCLA's Brain Research Institute. "These findings suggests that desirable outcomes for smoking cessation and drinking reduction are achievable."
The study, which found no difference in quit and reduction rates between men and women, was published online in the American Journal of Psychiatry June 3 and is scheduled for publication in the journal's September print issue.
Approximately 20% to 25% of smokers are also heavy drinkers. Smoking and heavy drinking are major public health concerns that reduce people's life span and quality of life, and both have also been linked to worse health outcomes for COVID-19.
As with all addictions, quitting smoking and reducing drinking are difficult and complex processes. This study confirms that medications can play a role, Ray said, but she noted that it can be challenging for patients to take more than one prescribed medication.
"Varenicline alone is doing a great job, and this trial indicates that there is not much room for naltrexone to make a difference," Ray said. "But even medications like varenicline have their limitations. Medication is only part of the solution. There remains much research to be done on addictions and how to treat them."
Ray says that those who wish to quit smoking and reduce drinking may consider talking to their doctor about the possibility of using varenicline, and she recommends that they try to quit smoking and reduce their drinking at the same time.
"There is evidence that varenicline can help them with both," Ray said. "Varenicline appears quite effective at reducing drinking and helping people to quit smoking. Given that varenicline has been found to reduce drinking in trials for alcohol use disorder, it is possible that its effects on both drinking and smoking present an optimal alternative for this group of heavy-drinking smokers."
ReJoyce Green, a UCLA doctoral student in clinical psychology who works with Ray, and Karen Miotto, a UCLA clinical professor of psychiatry and the medical director of the clinical trial, are among the study's 14 authors.
The clinical trial and Ray's research are funded by the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, both part of the National Institutes of Health.
The study was conducted between July 2015 and December 2019 at an outpatient research facility at UCLA.
INFORMATION:
Hippopotamus aren't the first thing that come to mind when considering epidemiology and disease ecology. And yet these amphibious megafauna offered UC Santa Barbara ecologist Keenan Stears(link is external) a window into the progression of an anthrax outbreak that struck Ruaha National Park, Tanzania, in the dry season of 2017.
Through surveys and GPS monitoring, Stears and his colleagues, Wendy Turner, Doug McCauley and Melissa Schmitt, revealed that reduced dry-season flows in the Great Ruaha River indirectly spread the disease by affecting hippo movement. The results, which appear in the journal Ecosphere(link is external), present a unique perspective on disease ecology and illustrate how anthropogenic changes can impact wildlife and human health.
The ...
A team of scientists at Nanyang Technological University, Singapore (NTU Singapore) has developed millimetre-sized robots that can be controlled using magnetic fields to perform highly manoeuvrable and dexterous manipulations. This could pave the way to possible future applications in biomedicine and manufacturing.
The research team created the miniature robots by embedding magnetic microparticles into biocompatible polymers -- non-toxic materials that are harmless to humans. The robots are 'programmed' to execute their desired functionalities when magnetic fields are applied.
The made-in-NTU robots improve on many existing small-scale robots by optimizing their ability to move ...
Is artificial intelligence the key to preventing relapse of severe mental illness?
New AI software developed by researchers at Flinders University shows promise for enabling timely support ahead of relapse in patients with severe mental illness.
The AI2 (Actionable Intime Insights) software, developed by a team of digital health researchers at Flinders University, has undergone an eight-month trial with psychiatric patients from the Inner North Community Health Service, located in Gawler, South Australia.
The digital tool is tipped to revolutionise consumer-centric timely mental health treatment provision outside hospital, with researchers labelling it as readily available and scalable.
In the trial of 304 ...
Exposure to the rhinovirus, the most frequent cause of the common cold, can protect against infection by the virus which causes COVID-19, Yale researchers have found.
In a new study, the researchers found that the common respiratory virus jump-starts the activity of interferon-stimulated genes, early-response molecules in the immune system which can halt replication of the SARS-CoV-2 virus within airway tissues infected with the cold.
Triggering these defenses early in the course of COVID-19 infection holds promise to prevent or treat the infection, ...
Researchers from The Australian National University (ANU) have developed new technology that allows people to see clearly in the dark, revolutionising night-vision.
The first-of-its-kind thin film, described in a new article published in Advanced Photonics, is ultra-compact and one day could work on standard glasses.
The researchers say the new prototype tech, based on nanoscale crystals, could be used for defence, as well as making it safer to drive at night and walking home after dark.
The team also say the work of police and security guards - who regularly employ night vision - will be easier and safer, reducing chronic neck injuries from currently bulk night-vision devices.
"We have made the invisible visible," lead researcher Dr Rocio Camacho Morales said. ...
Data collected for over two decades shows that rising Baltic Sea water temperature is one of the main factors in the increasingly earlier appearance and faster growth of Baltic herring larvae.
Baltic herring (Clupea harengus membras) is commercially the most important fish species in Finland, and an important part of the Baltic marine ecosystem. Conditions during herring spawning may have cascading effects on the whole Baltic ecosystem.
According to a recent research, both developmental stages in Baltic herring larvae, small and large, have shifted their timing to earlier dates.
"This suggests that herring spawn earlier and larvae grow faster, by about 7.7 days per decade. Water ...
Rising numbers of liver cancer in Aboriginal and Torres Strait Islander communities has led experts at Flinders University to call for more programs, including mobile liver clinics and ultrasound in rural and remote Australia.
The Australian study just published in international Lancet journal EClinicalMedicine reveals the survival difference was largely accounted for by factors other than Indigenous status - including rurality, comorbidity burden and lack of curative therapy.
The study of liver cancer, or Hepatocellular carcinoma (HCC), included 229 Indigenous and 3587 non-Indigenous HCC cases in South Australia, Queensland and the ...
Osaka, Japan - On the outside, animals often appear bilaterally symmetrical with mirror-image left and right features. However, this balance is not always reflected internally, as several organs such as the lungs and intestines are left-right (LR) asymmetrical. Researchers at Osaka University, using an innovative technique for imaging movement of cell nuclei in living tissue, have determined the patterns of nuclear alignment responsible for LR-asymmetrical shaping of internal organs in the developing embryo.
Embryogenesis involves complex genetic and molecular processes that transform a single-celled zygote into a complete, living individual with multiple functional axes, including the LR axis. A long-standing conundrum of Developmental ...
Researchers at the University of Helsinki and the Beatson Institute for Cancer Research in Glasgow have discovered how mutated cells promote their chances to form cancer. Typically, the accumulation of harmful cells is prevented by active competition between multiple stem cells in intestinal glands, called crypts.
"The functioning of intestinal stem cells relies on growth factors, named Wnts, produced by the surrounding environment. Intestinal cancers typically originate from stem cells where mutations allow growth independent of these factors. When we removed a gene called Notum, which renders Wnts inactive, from mutated stem cells, the number of precancerous adenomas in the intestine was greatly reduced. We found that ...
Echoing through history by reviving fungal specimens originally preserved and described a flabbergasting quarter of a millenium ago by the "Father of Modern Taxonomy" Carl Linnaeus, this study highlights the untapped potential of museum collections in modern research programmes. The results have just been published in the renowned Cell Press journal iScience.
The "desert coprinus" fungus Podaxis has fascinated scientists and explorers for centuries, still the genus has been subjected to relatively little research. These large mushrooms thrive in hostile and mostly species-free environments and while they occur seasonally ...
